메뉴 건너뛰기
Current Opinion in Organ Transplantation
Volumn 11, Issue 4, 2006, Pages 351-352
Allograft tolerance: Is it a journey towards achieving the impossible?
Author keywords

[No Author keywords available]
Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;
EID: 33746328339     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000236695.22340.24     Document Type: Editorial
Times cited : (3)
References (8)
  • 1
    • 0000658958 scopus 로고
    • Immunogenic consequences of vascular anastomoses between bovine twins
    • Owen RD. Immunogenic consequences of vascular anastomoses between bovine twins. Science 1945; 102:400-404.
    • (1945) Science , vol.102 , pp. 400-404
    • Owen, R.D.1
  • 2
    • 0005984244 scopus 로고
    • Actively acquired tolerance of foreign cells
    • Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172:603-606.
    • (1953) Nature , vol.172 , pp. 603-606
    • Billingham, R.E.1    Brent, L.2    Medawar, P.B.3
  • 3
    • 15844404353 scopus 로고    scopus 로고
    • Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
    • Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381:434-438.
    • (1996) Nature , vol.381 , pp. 434-438
    • Larsen, C.P.1    Elwood, E.T.2    Alexander, D.Z.3
  • 4
    • 4544246589 scopus 로고    scopus 로고
    • Prope tolerance: The future of organ transplantation from the laboratory to the clinic
    • Calne RY. Prope tolerance: the future of organ transplantation from the laboratory to the clinic. Transpl Immunol 2004; 13:83-86.
    • (2004) Transpl Immunol , vol.13 , pp. 83-86
    • Calne, R.Y.1
  • 5
    • 0042532322 scopus 로고    scopus 로고
    • Heterologous immunity provides a potent barrier to transplantation tolerance
    • Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111:1887-1895.
    • (2003) J Clin Invest , vol.111 , pp. 1887-1895
    • Adams, A.B.1    Williams, M.A.2    Jones, T.R.3
  • 6
    • 0344613988 scopus 로고    scopus 로고
    • Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
    • Li Y, Li XC, Zheng XX, et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999; 5:1298-1302.
    • (1999) Nat Med , vol.5 , pp. 1298-1302
    • Li, Y.1    Li, X.C.2    Zheng, X.X.3
  • 7
    • 1842480959 scopus 로고    scopus 로고
    • TGF-beta regulates in vivo expansion of FoxP3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes
    • U S A
    • Peng Y, Laouar Y, Li MO, et al. TGF-beta regulates in vivo expansion of FoxP3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A 2004; 101:4572-4577.
    • (2004) Proc Natl Acad Sci , vol.101 , pp. 4572-4577
    • Peng, Y.1    Laouar, Y.2    Li, M.O.3
  • 8
    • 20444373376 scopus 로고    scopus 로고
    • Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
    • Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005; 105:4743-4748.
    • (2005) Blood , vol.105 , pp. 4743-4748
    • Battaglia, M.1    Stabilini, A.2    Roncarolo, M.G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.